290 related articles for article (PubMed ID: 25996664)
21. Identification of CRM1-dependent Nuclear Export Cargos Using Quantitative Mass Spectrometry.
Thakar K; Karaca S; Port SA; Urlaub H; Kehlenbach RH
Mol Cell Proteomics; 2013 Mar; 12(3):664-78. PubMed ID: 23242554
[TBL] [Abstract][Full Text] [Related]
22. XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.
Kim J; McMillan E; Kim HS; Venkateswaran N; Makkar G; Rodriguez-Canales J; Villalobos P; Neggers JE; Mendiratta S; Wei S; Landesman Y; Senapedis W; Baloglu E; Chow CB; Frink RE; Gao B; Roth M; Minna JD; Daelemans D; Wistuba II; Posner BA; Scaglioni PP; White MA
Nature; 2016 Oct; 538(7623):114-117. PubMed ID: 27680702
[TBL] [Abstract][Full Text] [Related]
23. Involvement of CRM1, a nuclear export receptor, in mRNA export in mammalian cells and fission yeast.
Watanabe M; Fukuda M; Yoshida M; Yanagida M; Nishida E
Genes Cells; 1999 May; 4(5):291-7. PubMed ID: 10421839
[TBL] [Abstract][Full Text] [Related]
24. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1.
Kudo N; Wolff B; Sekimoto T; Schreiner EP; Yoneda Y; Yanagida M; Horinouchi S; Yoshida M
Exp Cell Res; 1998 Aug; 242(2):540-7. PubMed ID: 9683540
[TBL] [Abstract][Full Text] [Related]
25. KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.
Etchin J; Sanda T; Mansour MR; Kentsis A; Montero J; Le BT; Christie AL; McCauley D; Rodig SJ; Kauffman M; Shacham S; Stone R; Letai A; Kung AL; Thomas Look A
Br J Haematol; 2013 Apr; 161(1):117-27. PubMed ID: 23373539
[TBL] [Abstract][Full Text] [Related]
26. Novel small molecule XPO1/CRM1 inhibitors induce nuclear accumulation of TP53, phosphorylated MAPK and apoptosis in human melanoma cells.
Yang J; Bill MA; Young GS; La Perle K; Landesman Y; Shacham S; Kauffman M; Senapedis W; Kashyap T; Saint-Martin JR; Kendra K; Lesinski GB
PLoS One; 2014; 9(7):e102983. PubMed ID: 25057921
[TBL] [Abstract][Full Text] [Related]
27. Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer.
Gao J; Azmi AS; Aboukameel A; Kauffman M; Shacham S; Abou-Samra AB; Mohammad RM
Oncotarget; 2014 Jun; 5(11):3444-54. PubMed ID: 24899509
[TBL] [Abstract][Full Text] [Related]
28. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export.
Daelemans D; Afonina E; Nilsson J; Werner G; Kjems J; De Clercq E; Pavlakis GN; Vandamme AM
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14440-5. PubMed ID: 12374846
[TBL] [Abstract][Full Text] [Related]
29. TNF stimulates nuclear export and secretion of IL-15 by acting on CRM1 and ARF6.
Ouyang S; Hsuchou H; Kastin AJ; Pan W
PLoS One; 2013; 8(8):e69356. PubMed ID: 23950892
[TBL] [Abstract][Full Text] [Related]
30. Ratjadones inhibit nuclear export by blocking CRM1/exportin 1.
Köster M; Lykke-Andersen S; Elnakady YA; Gerth K; Washausen P; Höfle G; Sasse F; Kjems J; Hauser H
Exp Cell Res; 2003 Jun; 286(2):321-31. PubMed ID: 12749860
[TBL] [Abstract][Full Text] [Related]
31. Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export.
Strunze S; Trotman LC; Boucke K; Greber UF
Mol Biol Cell; 2005 Jun; 16(6):2999-3009. PubMed ID: 15814838
[TBL] [Abstract][Full Text] [Related]
32. Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-Inhibitor.
Sui M; Xiong M; Li Y; Zhou Q; Shen X; Jia D; Gou M; Sun Q
Int J Nanomedicine; 2021; 16():2833-2847. PubMed ID: 33883894
[TBL] [Abstract][Full Text] [Related]
33. Nuclear export of BATF2 enhances colorectal cancer proliferation through binding to CRM1.
Zhou J; Lei Z; Chen J; Liao S; Chen Y; Liu C; Huang S; Li L; Zhang Y; Wang P; Huang Y; Li J; Liang H
Clin Transl Med; 2023 May; 13(5):e1260. PubMed ID: 37151195
[TBL] [Abstract][Full Text] [Related]
34. Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection.
Lu C; Figueroa JA; Liu Z; Konala V; Aulakh A; Verma R; Cobos E; Chiriva-Internati M; Gao W
Curr Cancer Drug Targets; 2015; 15(7):575-92. PubMed ID: 26324128
[TBL] [Abstract][Full Text] [Related]
35. The Cellular Distribution of RanGAP1 Is Regulated by CRM1-Mediated Nuclear Export in Mammalian Cells.
Cha K; Sen P; Raghunayakula S; Zhang XD
PLoS One; 2015; 10(10):e0141309. PubMed ID: 26506250
[TBL] [Abstract][Full Text] [Related]
36. Atomic basis of CRM1-cargo recognition, release and inhibition.
Fung HY; Chook YM
Semin Cancer Biol; 2014 Aug; 27():52-61. PubMed ID: 24631835
[TBL] [Abstract][Full Text] [Related]
37. Biogenesis and nuclear export of ribosomal subunits in higher eukaryotes depend on the CRM1 export pathway.
Thomas F; Kutay U
J Cell Sci; 2003 Jun; 116(Pt 12):2409-19. PubMed ID: 12724356
[TBL] [Abstract][Full Text] [Related]
38. Crystallization of Nuclear Export Signals or Small-Molecule Inhibitors Bound to Nuclear Exporter CRM1.
Fung HYJ; Chook YM
Methods Mol Biol; 2022; 2502():285-297. PubMed ID: 35412246
[TBL] [Abstract][Full Text] [Related]
39. The nucleoporin Nup214 sequesters CRM1 at the nuclear rim and modulates NFkappaB activation in Drosophila.
Xylourgidis N; Roth P; Sabri N; Tsarouhas V; Samakovlis C
J Cell Sci; 2006 Nov; 119(Pt 21):4409-19. PubMed ID: 17032737
[TBL] [Abstract][Full Text] [Related]
40. Identification of nuclear export inhibitors with potent anticancer activity in vivo.
Mutka SC; Yang WQ; Dong SD; Ward SL; Craig DA; Timmermans PB; Murli S
Cancer Res; 2009 Jan; 69(2):510-7. PubMed ID: 19147564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
